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Abstract
Background Previous interventions have shown limited
success in improving medication adherence in older adults,
and this may be due to the lack of a theoretical underpinning.
Objective This review sought to determine the effective-
ness of theory-based interventions aimed at improving
medication adherence in older adults prescribed polyphar-
macy and to explore the extent to which psychological
theory informed their development.
Data Sources Eight electronic databases were searched
from inception to March 2015, and extensive hand-
searching was conducted.
Eligibility Criteria Interventions delivered to older adults
(populations with a mean/median age of C65 years) pre-
scribed polypharmacy (four or more regular oral/non-oral
medicines) were eligible. Studies had to report an under-
pinning theory and measure at least one adherence and one
clinical/humanistic outcome.
Review Methods Data were extracted independently by
two reviewers and included details of intervention content,
delivery, providers, participants, outcomes and theories
used. The theory coding scheme (TCS) was used to assess
the extent of theory use.
Results Five studies cited theory as the basis for inter-
vention development (social cognitive theory, health belief
model, transtheoretical model, self-regulation model). The
extent of theory use and intervention effectiveness in terms
of adherence and clinical/humanistic outcomes varied
across studies. No study made optimal use of theory as
recommended in the TCS.
Conclusions The heterogeneity observed and inclusion of
pilot designs mean conclusions regarding effectiveness of
theory-based interventions targeting older adults prescribed
polypharmacy could not be drawn. Further primary
research involving theory as a central component of
intervention development is required. The review findings
will help inform the design of future theory-based adher-
ence interventions.
Key Points
Theory is rarely used in the development of
adherence interventions for older adults prescribed
polypharmacy.
Details of exactly how theory informs intervention
development are often lacking.
More adherence interventions with a robust
theoretical basis are required.
1 Introduction
Older adults, aged C65 years, commonly suffer from
multi-morbidity (i.e. two or more long-term conditions)
[1–3]. The treatment of multi-morbid older adults often
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leads to the prescribing of multiple medications, often
referred to as polypharmacy [4, 5]. There is no standard
definition of polypharmacy and it is commonly defined
using arbitrary cut-off points, such as ‘the concomitant use
of four or more medications’ [5–7].
Adherence is described as ‘the extent to which a per-
son’s behaviour-taking medication, following a diet, and/or
executing lifestyle changes, corresponds with agreed rec-
ommendations from a healthcare provider’ [8]. Adherence
can be challenging for older adults prescribed polyphar-
macy, with research showing that increases in both the
number of prescribed medications and regimen complexity
are correlated with lower medication adherence [8, 9].
Complex regimens are particularly difficult to manage, as
they can involve a variety of formulations, multiple daily
doses and, in some instances, special administration
instructions (e.g. take 1 h before food) [5, 10, 11]. Cog-
nitive and physiological changes (e.g. swallowing diffi-
culties) that occur with increasing age can also act as
barriers to adherence. Non-adherence can be either inten-
tional in nature (i.e. involving a conscious decision-making
process) or un-intentional, whereby the patient wants to
follow the treatment plan but faces practical difficulties
(e.g. forgetfulness) [12]. However, both types of non-ad-
herence can be observed in some patients. Non-adherence
rates in older adults range from 25 to 75% and have been
linked to poor clinical outcomes and increases in hospital
admissions and healthcare costs [13, 14]. Consequently,
improving adherence to long-term medications in this
population group is a key international priority for policy
makers, researchers and healthcare professionals alike
[8, 15, 16].
To date, interventions that have aimed to improve
adherence to prescribed treatments in all patient groups
have shown limited effectiveness in improving clinical
outcomes and are often too costly or difficult to implement
in practice [17]. Several challenges are associated with the
design and delivery of adherence interventions. First, the
choice of adherence measure selected to demonstrate the
effect of the intervention requires careful consideration. A
variety of methods are available but no ‘gold standard’
approach exists. Direct measures (e.g. drug-level moni-
toring) are seen as evidence that the medication has been
consumed but are often time-consuming, expensive and
impractical for research purposes. Alternatively, less
expensive indirect measures involve some degree of
assumption that the patient has consumed the medication,
leading to an overestimation of adherence (e.g. self-report)
[18–20]. Combining indirect measures has been suggested
as one way of overcoming their individual limitations [8].
Adherence measures are used in research to categorise
participants as either adherent or non-adherent, for exam-
ple, an arbitrary cut-off point of consuming more than 80%
of recommended doses is commonly used to categorise
participants as adherent [21].
The second challenge with adherence research involves
the complexity of the behaviour being targeted as well as
the types of interventions developed in an attempt to bring
about behaviour change. Complex interventions consisting
of ‘multiple interacting components’ are often selected as
the intervention type, but a consistent approach to their
development and reporting has been lacking, making
evaluation and replication difficult [22]. To assist
researchers, the UK Medical Research Council (MRC)
produced guidelines that recommend a systematic
approach to intervention development and evaluation, with
greater emphasis placed on the supporting evidence base
and the use of theory (e.g. psychological theories) [22].
One potential explanation for the limited success of pre-
vious adherence interventions could be the lack of an
explicit theoretical underpinning [17, 23]. Theory (‘a set of
concepts, definitions, and propositions that explain or
predict … events or situations by illustrating the relation-
ship between variables’) has the potential to assist
researchers’ understanding of the behaviour change process
and guide intervention development and refinement
[24, 25]. For example, theory can assist in the identification
of theoretical constructs to target as part of the intervention
(e.g. ‘self-efficacy’) or of participants to include in the
study (e.g. patients with low ‘self-efficacy’) [22, 26, 27].
Theoretical constructs can also be measured pre- and post-
intervention, allowing researchers to understand the inter-
vention’s mechanism of action and to refine the interven-
tion and its underlying theory [27].
Previous reviews of behaviour change interventions that
target health behaviours (e.g. HIV prevention) have
examined theory use in a more simplistic fashion, by
simply comparing interventions that have cited theory with
those that did not [28–30]. A recent meta-analysis of
medication adherence interventions (delivered to adults
aged[18 years) examined theory use by simply identify-
ing those that had made reference to a theory or particular
intervention approach that is commonly linked to theory
(e.g. motivational interviewing [MI]) [30]. This review
identified 146 interventions that, overall, produced a
modest effect size of 0.294. Although the authors indicated
that this modest effect may have been influenced by poor
theory selection, application and operationalisation, they
did not undertake a detailed examination of exactly how
theory was used to develop or evaluate the interventions.
Experts in the field of behaviour change have recognised
that the specific way in which theory is used can affect the
outcome of the intervention [26, 27]. A theory coding
scheme (TCS) has been developed as a method for deter-
mining the extent to which interventions are ‘theory based’
[27]. This research tool allows reviewers to systematically
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identify and reliably describe an intervention’s theory base
and has been adopted in a number of systematic reviews on
behaviour change [26, 27, 31–33].
To date, no review has specifically investigated the use
of psychological theories in the design of interventions
targeting adherence in older adults prescribed polyphar-
macy. Therefore, the aim of this review was to determine
the overall effectiveness of theory-based interventions on
adherence and clinical/humanistic outcomes in older adults
prescribed polypharmacy and explore the extent to which
psychological theory informed intervention design. As the
choice of adherence measure can affect outcomes, this
review also examined measures investigated by included
studies.
2 Methods
2.1 Protocol
The methods used in this review followed those established
by the Cochrane Collaboration [34]. The protocol can be
obtained from the corresponding author upon request. The
review findings are reported in line with the PRISMA
(Preferred Reporting Items for Systematic Reviews and
Meta-Analyses) statement [35].
2.2 Eligibility Criteria
Studies were included if they met the relevant criteria
specified in the Cochrane Effective Practice and Organi-
sation of Care (EPOC) Review Group’s Data Collection
Checklist, i.e. randomised controlled trials (RCTs), non-
randomised controlled clinical trials, interrupted time ser-
ies studies and controlled before-and-after studies [36].
Pilot RCTs were also eligible as there has been encour-
agement towards the use of theory in intervention design,
and studies could potentially be in the preliminary stages of
development [22].
Studies were included if the population had a mean (or
median) age of at least 65 years and were taking a mean (or
median) of four or more medications (i.e. the definition of
polypharmacy stated in Sect. 1) [7]. Any type of inter-
vention to improve adherence was considered for inclusion
provided the intervention had a comparative control group.
Similar to a recent Cochrane review on adherence inter-
ventions [17], eligible studies had to include at least one
medication adherence outcome and one clinical outcome
(e.g. hospitalisations) or humanistic outcome (e.g. health-
related quality of life [HRQOL]).
Studies were excluded if they did not explicitly state that
an established theory (or theoretical framework) under-
pinned their intervention. Cited theories had to meet the
definition proposed by Glanz and Rimer [25], as noted in
Sect. 1. Studies focusing on patients with opioid, alcohol or
tobacco addictions were excluded from this review as these
problems are considerably more severe and generally differ
in nature [17, 37].
2.3 Information Sources/Search
A search of eight electronic databases (MEDLINE,
Embase, PsycINFO, SCOPUS, CINAHL, Web of Science,
International Pharmaceutical Abstracts, the Cochrane
Library) was conducted. Studies published in the English
language, from inception of the database to the search date
(March 2015), were considered for inclusion. Variations of
the following terms were used in the search strategy and
adapted for each database: ‘older adults’, ‘medication
adherence’, ‘polypharmacy’ and ‘theory’ (see MEDLINE
search string in Appendix S1 in the Electronic Supple-
mentary Material [ESM]). Reference lists and articles that
cited included studies were hand searched. Other sources
that were searched are detailed in Appendix S2 in the ESM.
2.4 Study Selection
After removal of duplicates, screening of study titles and
abstracts was undertaken independently by two reviewers
(DP, CR) to identify studies suitable for inclusion. Fol-
lowing this, full-text articles were retrieved and assessed
for eligibility. Disagreements were resolved through dis-
cussion and by consultation with a third reviewer (CC).
2.5 Data Collection and Analysis
A data extraction form was developed and piloted using
one of the studies agreed upon for inclusion and refined
before it was used to extract data from the remaining
studies. Two researchers (DP, CR) independently extracted
data using the data extraction form. Any disagreement, for
any component of data analysis, was resolved through
third-party discussion (CC).
Given the wide variety of outcomes measures and
intervention designs commonly reported in adherence
interventions, it was anticipated a priori that a meta-anal-
ysis would not be feasible [17]. Therefore, an in-depth
narrative analysis was chosen to present the review find-
ings. The extent of theory use in each included study was
evaluated using pre-defined categories from the TCS [27].
This coding scheme consists of 19 items, each of which
falls into at least one of six categories. Categories 1–3 deal
with the extent to which the intervention has been based on
theory, whereas categories 4–6 relate to theory testing and
refinement. The items in each category are detailed in
Table 1.
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Table 1 Categories of the theory coding scheme [27]
TCS category Relevant items of TCS Description
Category 1: Is theory
mentioned?
Theory/model of behaviour mentioned (TCS item 1) Models/theories that specify relations among variables to
explain or predict behaviour are mentioned, even if the
intervention is not based on this theorya
Targeted construct mentioned as predictor of behaviour
(TCS item 2)
Evidence that the psychological construct relates to
(correlates/predicts/causes) behaviour should be presented
within the introduction or methoda
Intervention based on a single theory (TCS item 3) The intervention is based on a single theory (rather than a
combination of theories or predictors)a
Category 2: Are relevant
theoretical constructs targeted
by the intervention?
Targeted construct mentioned as predictor of behaviour
(TCS item 2)
See above
Theory/predictors used to select/develop intervention
techniques (TCS item 5)
The intervention is explicitly based on a theory or predictor
or combination of theories or predictorsa
Intervention techniques(s) linked to theory-relevant
construct(s)
All intervention techniques are explicitly linked to at
least one theory-relevant construct/predictor (TCS
item 7)
Each intervention technique is explicitly linked to at least
one theory-relevant construct/predictora
At least one, but not all, of the intervention techniques
are explicitly linked to at least one theory-relevant
construct/predictor (TCS item 8)
At least one, but not all, of the intervention techniques are
explicitly linked to at least one theory-relevant construct/
predictora
Group of techniques are linked to a group of constructs/
predictors (TCS item 9)
A cluster of techniques is linked to a cluster of constructs/
predictorsa
Theory-relevant construct(s) linked to intervention
techniques(s)
All theory-relevant constructs/predictors are explicitly
linked to at least one intervention technique (TCS item
10)
At least one, but not all, of the theory relevant
constructs/predictors are explicitly linked to at least
one intervention technique (TCS item 11)
Every theoretical construct within a stated theory, or every
stated predictor (see item 5), is linked to at least one
intervention techniquea
At least one, but not all, of the theoretical constructs within
a stated theory or at least one, but not all, of the stated
predictors (see item 5) are linked to at least one
intervention techniquea
Category 3: Is theory used to
select intervention recipients
or tailor interventions?
Theory/predictors used to select recipients for the
intervention (TCS item 4)
Participants were screened/selected based on achieving a
particular score/level on a theory-relevant construct/
predictora
Theory/predictors used to tailor intervention techniques
to recipients (TCS item 6)
The intervention differs for different sub-groups that vary
on a psychological construct (e.g. stage of change) or
predictor at baselinea
Category 4: Are the relevant
theoretical constructs
measured?
Theory-relevant constructs/predictors are measured
(TCS item 12)
At least one construct of theory (or predictor) mentioned in
relation to the intervention is measured post-intervention
At least one construct of theory (or predictor) mentioned in
relation to the intervention is measured pre- and post-
interventiona
Quality of measures (TCS item 13) All of the measures of theory-relevant constructs/predictors
had some evidence for their reliability
At least one, but not all, of the measures of theory relevant
constructs/predictors had some evidence for their
reliability
All of the measures of theory relevant constructs/predictors
have been previously validated
At least one, but not all, of the measures of theory relevant
constructs/predictors have been previously validated
The behaviour measure had some evidence for its reliability
The behaviour measure has been previously validateda
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2.6 Risk of Bias of Individual Studies
The reviewers (DP, CR) conducted independent risk-of-
bias assessments using tools developed by the Cochrane
Collaboration (‘risk of bias’ tool for randomised studies
and ‘suggested risk of bias criteria for EPOC reviews’ for
non-randomised studies) [34, 36]. Studies were assigned an
overall rating of low, high or unclear risk.
3 Results
3.1 Study Selection
The electronic searches identified 4366 citations, and hand
searching identified a further 33 citations. Following title
and abstract screening, 76 full-text articles were retrieved
and reviewed for eligibility of inclusion. Five studies met
the inclusion criteria: one RCT [38] and four pilot RCTs
[39–42] (Fig. 1).
3.2 Study Characteristics
As expected, the included studies were heterogeneous in
terms of outcome measures, targeted clinical conditions
and psychological theories underpinning intervention
design. In addition, four of the studies were pilot RCTs
with small sample sizes. Therefore, a narrative summary is
provided that outlines how each study reported the use of
theory during intervention development. Outcome data
have been summarised to give an indication of preliminary
findings [43].
A total of 2294 participants were recruited across all five
studies (range 15–2097). The mean age of participants
ranged from 67 to 78 years, and the mean number of reg-
ularly prescribed medications ranged from 5.5 to 11.25
medications. Four studies targeted individual clinical con-
ditions (hypertension [40], osteoporosis [38], heart failure
[39], stroke [42]), and one study focused on co-existing
conditions (diabetes and chronic kidney disease) [41].
Although the study populations were prescribed a mean of
Table 1 continued
TCS category Relevant items of TCS Description
Category 5: Is theory tested? Theory relevant constructs/predictors are measured
(TCS item 12)
See above
Quality of measures (TCS item 13) See above
Randomization of participants to condition (TCS item
14)
Do the authors claim randomization?
Is a method of random allocation to condition described
(e.g. random number generator)?
Was the success of randomization tested?
Was the randomization successful (or baseline differences
between intervention and control group statistically
controlled)?a
Changes in measured theory-relevant constructs/
predictors (TCS item 15)
The intervention leads to significant change in at least one
theory-relevant construct/predictor (vs. control group) in
favour of the interventiona
Meditational analysis of constructs/predictors (TCS
item 16)
Any evidence of hypothesized mediating variable or change
in hypothesized mediating variable predicting
independent variablea
Results discussed in relation to theory (TCS item 17) Results are discussed in terms of the theoretical basis of the
interventionb
Appropriate support for theory (TCS item 18) Support for the theory is based on appropriate mediation
OR refutation of the theory is based on obtaining
appropriate null effects (i.e. changing behaviour without
changing the theory-relevant constructs)a
Category 6: Is theory refined? Results used to refine theory (TCS item 19) The authors attempt to refine the theory upon which the
intervention was based by either (1) adding or removing
constructs to the theory, or (2) specifying that the
interrelationships between the theoretical constructs
should be changed and spelling out which relationships
should be changeda
TCS theory coding scheme
a Explanation reproduced from the original TCS paper by Michie and Prestwich [27]
b Explanation reproduced from Farmer et al. [31]
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four or more medications, only two studies measured
adherence to all prescribed medications [39, 41]; the other
studies measured adherence to a group of medications used
to treat the particular condition that was the intervention
target [40, 42, 44]. Four studies used a cut-off point to
classify patients as adherent using self-report scores, pill
counts or electronic monitoring [38–40, 42]. Two studies
specifically recruited patients who were classified as non-
adherent [40, 42].
All of the interventions were complex in nature and
included a range of educational and behavioural tech-
niques, such as self-monitoring [41], prompts [40], feed-
back [40] and MI [38, 41]. Intervention participants
received between one and eight sessions, ranging from 2 to
89 min in duration. Participants were followed-up for
various time periods, from 3 to 12 months. Adherence
measures varied across studies, with three studies relying
on a single measure [38–40]. These included self-report
[39, 41, 45, 46], medication possession ratios (MPRs)
calculated using pharmacy dispensing records [38], pill
counts [41] and electronic monitoring using medication
event monitoring systems (MEMS) [40]. The clinical out-
comes measured depended on the clinical condition tar-
geted, for example, a change in blood pressure
(hypertension) [40] and self-reported falls and fractures
(osteoporosis) [38]. Two studies also measured humanistic
outcomes (e.g. HRQOL) [38, 39, 47]. A summary of the
characteristics of included studies is provided in Table 2.
3.3 Theoretical Underpinning of Included Studies
All of the included studies were originally based on a
single theory, although O’Carroll et al. [42] also made
reference to a separate related theory in a linked publica-
tion [48] regarding a process evaluation; this is discussed in
more detail below (Sect. 3.3.2). The majority of included
studies in this review were small-scale pilot studies, and
only one study reported testing the underpinning theory
[48]. None of the authors reported theory refinement based
on the study results. Consequently, we decided to focus
solely on categories 1–3 of the TCS for the purposes of this
in-depth narrative review, as these categories explore how
the researchers have used theory in developing their
interventions. A summary of the main findings from this
narrative analysis can be found in Table 3. An overall
judgement of ‘yes’, ‘no’ or ‘partially’ was made for each
TCS category based on whether the study met all, none or
some of the relevant TCS items (see Table 3).
3.3.1 Social Cognitive Theory
Barnason et al. [39] based their intervention on social
cognitive theory (SCT) (TCS category 1: yes) [24, 49]. The
intervention consisted of counselling and education and
was delivered to patients with heart failure (HF) upon
transition from secondary to primary care. SCT helps to
understand human thought and behaviour and includes a
Additional records 
identified through 
other sources 
(n = 33)
Records after duplicates removed
(n = 3588)
Records screened
(n = 3588)
Records excluded
(n = 3512)
Full-text articles assessed for 
eligibility 
(n = 76)
Full-text articles excluded (n = 71)
Main reasons for exclusion:
Ineligible study design (n = 27)
Patients under 65 years (n = 19)
Patients prescribed less than four 
medicines/not stated (n = 8)
Absence of theoretical base (n = 13)
Absence of adherence outcome (n = 2)
Conference abstract/ full results not 
available1 (n = 2)
Studies included in narrative synthesis
(n = 5)
Records identified 
through database 
searching 
(n = 4366)
Fig. 1 PRISMA flow diagram
of the systematic review
process. 1Authors were
contacted in both instances with
no response
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Table 3 A summary of the narrative analysis for included studies based on categories 1–3 of the theory coding scheme [27]
Study
(country)
Category 1: Is theory
mentioned?
Category 2: Are relevant theoretical constructs
targeted by the intervention?
Category 3: Is theory used to tailor the
intervention or select the intervention
recipients?
Yes, no,
or
partiallya
Reason Yes, no,
or
partiallyb
Reason Yes, no,
or
partiallyc
Reason
Barnason
et al. [39]
(USA)
Yesa Met TCS item 1
and 3
Bandura’s
SCT
Met TCS item 2
Refer to
category 2
Yesb Met TCS item 2 Targeted constructs of
SCT (e.g. self-regulation) were
mentioned as predictors of adherence
Met TCS item 5 Theory was used to select
intervention techniques (e.g. self-
monitoring selected based on self-
regulation construct of SCT)
Met TCS item 7 All intervention
techniques were linked to theoretical
constructs or predictors (e.g. verbal
persuasion technique linked to self-
efficacy)
Met TCS item 10 Targeted constructs
were linked explicitly to at least one
intervention technique
Partiallyc Met TCS item 6 Predictors
(e.g. motivation) were
examined via
questionnaires and used to
tailor the intervention to
individual patients
Did not meet TCS item 4
Intervention recipients
were not selected using
theory (e.g. based on
‘self-efficacy’ levels)
O’Carroll
et al.
[42, 48, 52]
(UK)
Yesa Met TCS items 1
and 3
Leventhal’s
SRM (also
made
reference to
Hall and
Fong’s
temporal self-
regulation
theory)
Met TCS item 2
Refer to
category 2
Yesb Met TCS item 2 Targeted construct of
SRM (‘illness perceptions’) was
mentioned as a predictor of adherence
Met TCS item 5 Theory was used to select
intervention techniques
Met TCS item 7 All intervention
techniques were linked to theoretical
constructs/predictors (e.g. information
about health consequences was linked to
illness perceptions)
Met TCS item 11 Targeted constructs/
predictors were linked explicitly to at
least one intervention technique
Noc Did not meet TCS item 6
Intervention was not
tailored based on theory
Did not meet TCS item 4
Intervention recipients
were selected based on a
self-report questionnaire
score but not specifically
using theory (e.g. based
on illness perceptions)
Ruppar [40]
(USA)
Yesa Met TCS item 1
and 3
Leventhal’s
SRM
Met TCS item 2
Refer to
category 2
Partiallyb Met TCS item 2 Targeted construct
(illness perceptions) was mentioned as a
predictor of adherence behaviour
Did not meet TCS item 5 Theory was not
used to select all intervention techniques
(e.g. prompts)
Met TCS item 8 At least one, but not all,
intervention techniques were explicitly
linked to theoretical constructs (e.g.
habit modification not linked to theory)
Met TCS item 11 Key theoretical
construct (illness perceptions) was
linked to intervention techniques
Noc Did not meet TCS item 6
Habit modification was
tailored but not linked to
theory
Did not meet TCS item 4
Intervention recipients
were not selected using
theory (e.g. based on their
illness perceptions)
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core reciprocal model whereby personal, behavioural and
environmental factors influence each other. The authors
indicated that personal factors (e.g. motivation) and envi-
ronmental factors (e.g. assistance from others) impacted on
the behaviour. Key constructs in this model are ‘self-effi-
cacy’ and ‘self-regulation’, and these were linked to
intervention techniques such as verbal persuasion and self-
monitoring, respectively (TCS category 2: yes). Some
techniques were also linked to the medication adherence
conceptual framework, which was used alongside the the-
oretical basis to guide intervention design. This conceptual
framework, developed based on a literature review, links
closely with SCT and focuses on ‘the relationship between
environmental factors, patient characteristics, and medi-
cation adherence as a process that ultimately affects patient
outcomes’ in older adults with HF [50]. SCT was not used
Table 3 continued
Study
(country)
Category 1: Is theory
mentioned?
Category 2: Are relevant theoretical constructs
targeted by the intervention?
Category 3: Is theory used to tailor the
intervention or select the intervention
recipients?
Yes, no,
or
partiallya
Reason Yes, no,
or
partiallyb
Reason Yes, no,
or
partiallyc
Reason
Solomon et al.
[38, 44]
(USA)
Partiallya Met TCS item 1
and 3
Prochaska’s
TTM
Did not meet
TCS item 2
Refer to
category 2
Nob Did not meet TCS item 2 The authors did
not explicitly indicate that the
constructs of TTM (e.g. stage of change,
process of change, self-efficacy) were
predictors of adherence
Did not meet TCS item 5 Theory did not
appear to guide the selection of MI
techniques. MI techniques appear to
have been selected based on similar
interventions and then linked back to
theory
Did not meet TCS item 7, 8 or 9 MI
techniques were not directly linked back
to constructs within the model
Did not meet TCS item 10 or 11 Key
constructs of TTM were not explicitly
linked to MI techniques
Noc Did not meet TCS item 6
The authors did report
that MI is based on an
‘individual’s readiness for
change’, but they did not
link this to their own
intervention
Did not meet TCS item 4
Intervention recipients
were not selected using
theory (e.g. based on their
‘stage of change’)
Williams et al.
[41, 57]
(Australia)
Yesa Met TCS item 1
and 3 HBM
(modified)
Met TCS item 2
Refer to
category 2
Partiallyb Met TCS item 2 Targeted constructs of the
modified HBM were mentioned as
predictors of adherence (e.g. self-
efficacy)
Did not meet TCS item 5 Theory was not
used to select all intervention techniques
(e.g. self-monitoring)
Met TCS item 8 At least one, but not all,
intervention techniques were explicitly
linked to theoretical constructs (e.g.
goal setting was not linked to
constructs)
Did not meet TCS item 10 or 11
Theoretical constructs were not
explicitly linked to intervention
techniques
Noc Did not meet TCS item 6MI
was tailored but not
linked to theory. Other
intervention techniques
were not tailored
Did not meet TCS item 4
Intervention recipients
were not selected using
theory (e.g. based on their
level of ‘self-efficacy’)
HBM health belief model, MI motivational interviewing, SCT social cognitive theory, SRM Self-Regulation Model, TCS theory coding scheme,
TTM transtheoretical model
a Judgement of ‘yes’ if study met TCS items 1, 2 and 3 in category 1. Judgement of ‘partially’ if study met any of the TCS items in category 1.
Judgement of ‘no’ if study did not meet any TCS items in category 1
b Judgement of ‘yes’ if study met TCS items 2 and 5 and 7, 8 or 9 and 10 or 11 in category 2. Judgement of ‘partially’ if study met any of the
TCS items in category 2. Judgement of ‘no’ if study did not meet any TCS items in category 2
c Judgement of ‘yes’ if study met TCS items 4 and 6 in category 3. Judgement of ‘partially’ if study met any of the TCS items in category 3.
Judgement of ‘no’ if study did not met any TCS items in category 3
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to select patients for inclusion in the trial but was used to
tailor the intervention based on an initial assessment of
personal factors (e.g. participants with low motivation were
given tailored information on the benefits of adherence)
(TCS category 3: partially). This intervention was tested in
a pilot study and led to statistically significant differences
in both self-reported adherence and HRQOL (see Table 2).
3.3.2 Self-Regulation Model
Leventhal’s Self-Regulation Model (SRM) [24, 51] was
cited as the basis for intervention development in two of
the included studies [40, 42]. First, SRM was cited by
Ruppar [40] as the basis of an intervention that aimed to
improve adherence to medicines prescribed for hyperten-
sion (TCS category 1: yes). SRM consists of three con-
structs: (1) ‘illness perceptions’ (i.e. the beliefs a person
holds about their illness), (2) ‘coping responses’/action
planning, (3) ‘appraisal’/monitoring of responses [51]. The
key construct in this model, ‘illness perceptions’, consists
of both cognitive perceptions (e.g. identity/illness label and
symptoms, cause, timeline, consequences and curabil-
ity/controllability) and emotional perceptions (e.g. anxiety,
depression, fear). In Ruppar’s study [40], SRM was dis-
cussed in terms of how it related to hypertension, as these
patients are commonly asymptomatic, in contrast to other
conditions, where symptoms act as feedback that medica-
tion doses have been missed (e.g. Parkinson’s disease). The
author proposed that a lack of feedback from ‘perceived
symptoms’ was a possible predictor of non-adherence. To
account for the lack of symptom feedback, the intervention
was based on feedback gained from blood pressure moni-
toring and medication-taking behaviour. Education on
health consequences of poorly controlled hypertension was
also linked to the ‘illness perceptions’ construct (i.e.
‘consequences’ dimension). However, other techniques,
such as habit analysis and prompts, were not explicitly
linked to theory (TCS category 2: partially). Participants
were not selected based on theory, nor was theory used to
tailor the intervention (TCS category 3: no). This pilot
study reported a statistically significant difference in
medication adherence between intervention and control at
the end of the intervention period (week 8). A significant
decrease in systolic blood pressure (SBP) was noted at
week 12 for the intervention group, but SBP increased
slightly again at week 20 (see Table 2).
O’Carroll et al. [42, 52] also cited Leventhal’s SRM as
the underpinning theory for an intervention that aimed to
improve adherence in stroke survivors (TCS category 1:
yes). The authors indicated that the two main intervention
components, modification of incorrect medication/illness
beliefs and action planning, would target intentional and
unintentional non-adherence, respectively. The first
intervention component was linked to the ‘illness percep-
tions’ construct of SRM. The second component was
linked to a predictor of medication adherence that had been
demonstrated in previous research (i.e. forgetfulness due to
cognitive impairment) [52]. In a process evaluation paper,
O’Carroll et al. [48] also made reference to a newer self-
regulation theory posed by Hall and Fong (temporal self-
regulation theory [TST]) [53]. TST incorporates a theo-
retical construct termed ‘behavioural pre-potency’ (‘pres-
ence of cues to action in the environment’), which the
authors linked to the action planning component (TCS
category 2: yes). Theory was not used to select intervention
recipients or tailor the intervention (TCS category 3: no).
This study led to improvements in objectively measured
adherence via MEMs, but this was only statistically sig-
nificant for the percentage of doses taken on schedule. Both
groups reported higher self-reported adherence at follow-
up, and this was significantly greater in the intervention
group. There were no statistically significant differences in
changes to blood pressure between groups (see Table 2).
3.3.3 Transtheoretical Model of Behaviour Change
Solomon et al. [38, 44] used MI as the basis of their tele-
phone intervention to improve adherence to medications
prescribed for osteoporosis. The transtheoretical model
(TTM) of behaviour change (also known as the stages of
change model) was cited as the underpinning theory for MI
[54]. TTM consists of multiple constructs: ‘stages of
change’, ‘process of change’, ‘self-efficacy’, ‘temptation’
and ‘decisional balance’. The ‘stages of change’ construct
consists of five sequential stages: pre-contemplation, con-
templation, preparation, action and maintenance [24]. It
appears that the authors selected MI based on success in
previous adherence studies and then linked the approach to
the TTM (TCS category 1: partially) [24, 54–56]. The
authors discussed MI in general, indicating that it makes
use of active listening and relationship building to allow
participants to evaluate risks and treatment options, but
they did not make explicit links between their intervention
and relevant theoretical constructs (TCS category 2: no).
The authors did not appear to use theory to select partici-
pants or report whether the intervention was tailored based
on theory (TCS category 3: no). Statistically significant
improvements in medication adherence, changes in self-
reported falls, fractures or general health were not reported
(see Table 2).
3.3.4 Health Belief Model
A modified version of the health belief model (HBM) was
cited by Williams et al. [41, 57] as the basis for a multi-
component behavioural and educational intervention
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delivered to patients with co-existing diabetes and chronic
kidney disease (TCS category 1: yes). The original HBM
consists of four key constructs: ‘perceived barriers’, ‘per-
ceived benefits’, ‘perceived severity’ and ‘perceived sus-
ceptibility’ [24, 58, 59]. This model suggests that an
individual’s thoughts and actions are mainly rational, and
the behaviour will be carried out if the perceived threat
(severity and susceptibility) is high and perceived benefits
outweigh barriers. The modified version incorporates the
additional construct ‘self-efficacy’ [60]. A psychosocial
DVD was proposed to exert its effect by ‘motivating people
to take their medications, appealing to knowledge, thoughts
and feelings’ [41]. It included information on the conse-
quences of hypertension and benefits of medications as well
as examples of patients sharing their experiences of taking
multiple medications. The authors indicated that individuals
who were confident in self-managing their health would be
more adherent. Confidence (i.e. ‘self-efficacy’) was linked
to aspects of the DVD, but other techniques that formed part
of this complex intervention, such as MI, self-monitoring
and goal setting, were not clearly linked to theory (TCS
category 2: partially). Theory was not used to select par-
ticipants or tailor the intervention in any way (TCS category
3: no). This pilot study reported no statistically significant
improvements in adherence or blood pressure control (see
Table 2). However, the authors noted that a larger study
might demonstrate significant differences.
3.4 Risk of Bias of Individual Studies
The risk of bias summary, displayed in Fig. 2, gives an
overview of the quality of included studies. An overall
assessment of low risk of bias was judged for four studies
[38, 40–42] and an unclear risk for the fifth [39].
4 Discussion
This is the first systematic review to provide an in-depth
examination of theory-based adherence interventions tar-
geting older adults who are prescribed polypharmacy. It
differs from other reviews as it has examined in detail the
extent to which theory was used in intervention develop-
ment [17, 30, 61–63].
4.1 Adherence and Clinical Outcomes
The type of adherence measure varied across studies, and
only two studies [41, 42] followed recommendations to
employ multiple measures [8]. At present, there is no
consensus or guidance on how best to measure adherence
to multiple medications. A daily polypharmacy possession
ratio has been proposed as a method to calculate adherence
using pharmacy dispensing data but requires further vali-
dation [64]. To allow adherence research to advance
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further, it is essential that robust methods of measuring
adherence to polypharmacy are developed and tested.
Only one study considered the impact of polypharmacy
on medication adherence and discussed the associated
challenges [41]. Reasons for non-adherence can vary
depending on the prescribed regimens and patients’ asso-
ciated beliefs. This has important implications for adher-
ence research, as a ‘one-size-fits-all’ intervention is
unlikely to benefit all patients. Consideration should be
given to how theory can be used to tailor the components of
complex interventions to individual patient’s needs. Stud-
ies that include participants who are classified as highly
adherent may find it difficult to demonstrate a significant
effect as there is limited scope for improvement (‘ceiling
effect’) [17, 40]. Future interventions need to specifically
target patients who are non-adherent at baseline.
The variety of clinical outcomes measured by included
studies reflects the range of clinical conditions targeted. For
studies that aim to target multi-morbid patients, generic
humanistic outcomes, such as HRQOL or healthcare util-
isation measures, may be more appropriate as opposed to
condition-specific clinical outcomes [17]. The development
of a core outcome set (‘an agreed standardized collection of
outcomes … which should be measured and reported, as a
minimum, in all trials for a specific clinical area’) would
aid comparisons of interventions targeting multi-morbid
patients prescribed polypharmacy [65].
4.2 Intervention Effectiveness
Pilot studies, which the MRC recommends should be part
of the preliminary evaluation of complex interventions,
are described as ‘a version of the main study that is run in
miniature to test whether the components of the main
study can all work together’ [66]. Although not powered
to test for significance, all of the included pilot studies
used some form of hypothesis testing, with three
describing the positive effects shown as significant
[39, 40, 42]. Results from pilot studies are not always
reported, and many fail to advance to definitive trials. On
the one hand, it is possible that a significant effect may be
missed in an underpowered pilot study; conversely, there
is also the chance of observing the opposite effect in a
larger definitive trial [67]. Consequently, the results of
pilot studies should be interpreted with caution. This
limitation was recognised by Williams et al. [41], whose
pilot study failed to show significant effects. Although
conclusions on the overall effectiveness of theory-based
studies cannot be drawn from this review, the findings
from the included studies are a stepping stone in the
advancement of the application of theory in designing
interventions [43, 66].
4.3 Theoretical Basis
Overall, few studies cited theory as a basis for their
intervention, and only one reported theory testing based on
study outcomes [48]. An in-depth analysis using categories
1–3 of the TCS indicated that the selection of intervention
components was not always guided by theory or was not
reported as such. Both studies that included MI did not
outline exactly how the key constructs of the cited theory
explicitly linked to MI techniques [56, 68]. MI was not
originally developed from a single theory, and although
some researchers have attempted to link it to various the-
ories (e.g. TTM, SCT), the mechanisms through which it
facilitates behaviour change remain unclear [69]. Solomon
et al. [38] described MI as a method that was ‘built upon
Prochaska’s transtheoretical model of behaviour change’
but did not make explicit links between theory and their
adherence intervention. This lack of theoretical under-
standing may be reflected in the design of this MI-based
intervention and the subsequent outcome. The other four
studies employed a more theory-driven approach whereby
theory guided the selection of intervention techniques
[39–42]. However, in two of these studies, not all tech-
niques were linked to theory [40, 41]. It is evident from the
analysis that theory could be utilised further, either in
recruiting participants or in tailoring the intervention to
their needs based on theoretical constructs. For example,
Barnason et al. [39] measured relevant theoretical con-
structs/predictors (e.g. motivation) and used these to tailor
the intervention to participants; this approach may have
influenced the positive effect seen. O’Carroll et al. [48]
have provided a useful example of how theory can be used
to explore the intervention’s mechanism of action in a
theory-based process evaluation.
All five interventions targeted the same behaviour (ad-
herence) but were based on a range of different psycho-
logical theories. With such a wide range of theories
available in the literature, selecting just one can be a dif-
ficult task. As a result, theory selection is commonly based
on experience, personal preference or what is ‘in fashion’
[23]. When selecting theory it is important to provide a
clear rationale; however, none of the study authors clearly
outlined their choice. However, it is possible that the
authors gave theory selection due consideration but did not
report this. Selecting the most appropriate theory can also
be challenging in instances where individual theories do
not cover all potential influences on the target behaviour.
Failure to consider all potentially relevant psychological
processes, such as non-reflective processes, may have
placed limitations on the types of techniques developed.
For example, SCT does not consider the role that habit has
to play in medication taking [49].
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To overcome the above challenges in theory selection
for behaviour change intervention development, a group of
health service researchers and health psychologists have
devised the theoretical domains framework (TDF), which
encompasses constructs from 33 behaviour change theo-
ries, including those cited by studies in this review [70, 71].
This consolidation of theories was recently supported by
Holmes et al. [63] in a systematic review that investigated
the application of four theories in observational and
experimental adherence research. A behavioural analysis
via quantitative or qualitative methods, using the TDF, can
aid the selection of ‘key influences’ (theoretical domains)
that can be targeted to elicit behaviour change [70]. These
‘key influences’ can then be explicitly linked to the most
appropriate behaviour change techniques (BCTs) (‘the
smallest components of behaviour change interventions
that on their own in favourable circumstances can bring
about change’), for example, goal setting and prompts/cues
[25, 27, 72–74]. A change in ‘key influences’ will, in
theory, lead to behaviour change [23]. Although the TDF
was originally developed in 2005, it has only gained sig-
nificant attention in the field of adherence research in
recent years, so it is unsurprising that the five included
studies did not make reference to this [75, 76].
The findings from studies in the current review (n = 5)
demonstrate that, even when cited, theory appears to be
under-utilised when designing interventions. Further research
needs to be conducted to draw definitive conclusions
regarding the effectiveness of theory-based interventions that
aim to improve adherence in older adults prescribed
polypharmacy. Other reviews of theory-based interventions
targeting health-related behaviours (e.g. physical activity,
diabetes self-management) have shown some marginally
positive effects, but—in common with this review—they
identified an overall under-utilisation of theory [26, 77, 78]. A
recent review that looked specifically at text messaging and
medication-use monitoring interventions to promote adher-
ence in patients with type 2 diabetes mellitus (in all age
groups) showed that only 4 of 11 trials stated an underlying
theory [31]. The review authors also used the TCS, but they
did not go beyond identifying the number of studies that met
each TCS item and the specific theory on which each inter-
vention was based. In contrast, the current review provides an
additional in-depth narrative discussion of each intervention,
which will inform the development of future theory-based
adherence interventions.
As Michie et al. [23] highlight, using an explicit theory
does not guarantee the intervention will be effective. It has
been proposed that, for theory to influence intervention
effectiveness, it must form a key component of rigorous
and systematic intervention development [26, 27]. It is
important to note that the use of theory in intervention
design is based primarily on principle and therefore more
empirical research is required to determine whether
appropriate use of theory does, in fact, lead to more
effective interventions [79]. A review by George et al. [80]
has presented findings from non-theory-based adherence
interventions (n = 8) delivered to older adults prescribed
polypharmacy. Effective interventions in this review
(n = 4) were resource intensive and had no common
components. Without a theoretical understanding of the
interventions’ mechanism of action, it is impossible to
decipher the essential ingredients that led to behaviour
change. The use of a theoretical basis has the potential to
advance the field of adherence research. Even if theory-
based interventions fail to produce a positive effect, they
can still be used to develop an understanding of what does
and does not work and, more importantly, provide better
insights into the underlying mechanism of action of inter-
vention components [23].
The TCS was used in this review to guide a detailed and
systematic evaluation of how theory was reportedly used
during intervention development. Future theory-based
adherence interventions should utilise the TCS to ensure
consistency in reporting [27]. This follows the WIDER
(Workgroup for Intervention Development and Evaluation
Research) guideline recommendations, which advocate that
researchers include detailed descriptions of the underpin-
ning design and proposed mechanism of change, including
any psychological theory [81]. Researchers should also
draw on the latest guidance, from both research organisa-
tions and the field of health psychology, when designing
complex theory-based interventions [22, 23, 75, 82].
4.4 Limitations
This review was limited to studies published in the
English language and delivered to older adults who were
prescribed a mean of four or more medications. Given the
paucity of adherence research that targets older adults,
studies were deemed eligible if the sample population had
a mean/median age of 65 years. As study inclusion/ex-
clusion age was not part of the eligibility criteria for this
review, studies may have included a small proportion of
patients who were aged\65 years. However, as noted in
Sect. 2.5, the outcome data were not pooled in a meta-
analysis and so this was not considered to have any sig-
nificant implications on the findings of the review.
Although extensive electronic and hand-searching strate-
gies were conducted for this review, studies that met the
inclusion criteria but were not adequately indexed in the
literature may have been missed. The TCS that was used
to guide the narrative summary relies solely on details
reported by authors in published articles. Studies that
made use of theory but failed to report this may also have
been overlooked.
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5 Conclusion
There is a lack of robust evidence on theory-based adherence
interventions targeting older adults prescribed polypharmacy
and, therefore, nooverall conclusionon their effectiveness can
be drawn at this stage. The extent of theory use in developing
adherence interventions varied across included studies, and
only one study reported theory testing. To enhance the
potential effectiveness of theory-based interventions aimed at
improving adherence, appropriate background work is
essential to inform intervention development. This involves
identifying appropriate theories to understand target beha-
viours before undertaking a systematic process of intervention
development and evaluation. The application of theory will
ultimately help researchers and clinicians understand the
mechanisms of action underlying intervention effects and
facilitate additional refinements where necessary.
There is a need for further empirical research that
incorporates theory into the intervention development
process. If theory is to have a positive impact on inter-
vention effectiveness, it needs to be a core component of
the design process as opposed to a loosely applied frame-
work. Those developing theory-based interventions should
consider the components of the TCS to help guide theory
use and articulate its role in published reports.
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